InvestorsHub Logo

marzan

06/01/19 11:05 AM

#230223 RE: radonculous #230220

radondoc, thanks for your active posting here. In your experience, have you seen this many patients about 80+ alive out of 331 total this long for about 45+ months since surgery. As you know the last patient had the surgery I guess was in Aug 2015. In that case, is there still a possibility L being as effective as SOC? There were only about 100 placebos. We are hearing testimonials from compassionate arm alive patients so many. How comes Checkpoint Inhibitors are approved left and right. They employ the same dendritic cells to attack the tumor once their breaker is turned off, imo. In DcVax the very same dendritic cells are amplified and processed to be more potent with all the tumor proteins impregnated as a vaccine. Which one in your opinion will do a better job? We are seeing CIs cause hyperprogression whereas DcVax doesn't. Sorry to ask you all these novice questions to a cancer doctor, but I am a serious investor here with a strong belief DcVax works, not just works but cures cancer if treated early on, imo. Again thanks for everything among your busy schedules.

survivor1x

06/01/19 11:20 AM

#230227 RE: radonculous #230220

Thank you. And thanks for the extras. I find lactate interesting because of another paper I read showing hypoxia induced mesenchymal shift.

If mesenchymal tumors work better with DCVAX and other immune therapies, then it would be important find a way that causes and can confirm this shift.